Unknown

Dataset Information

0

Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2.


ABSTRACT: The global COVID-19 pandemic has led to the rapid development of tests for detection of SARS-CoV-2. Studies are required to assess the relative performance of different assays. Here, we compared the performance of two commercial assays, the cobas® SARS-CoV-2 (Roche Diagnostics) and Xpert® Xpress SARS-CoV-2 (Cepheid®) tests, and a laboratory developed RT-PCR test adapted for use on the Hologic® Panther Fusion® (Hologic®) instrument as well as Bio-Rad and QIAGEN real-time PCR detection systems. Performance characteristics for each test were determined by testing clinical specimens and reference material. All assays detect the pan-Sarbecovirus E (envelope structural protein) gene plus a SARS-CoV-2-specific target. The limit of detection for the E gene target varied from ?2 copies/reaction to >30 copies/reaction. Due to assay-specific differences in sample processing and nucleic acid extraction, the overall analytical sensitivity ranged from 24 copies/mL specimen to 574 copies/mL specimen. Despite these differences, there was 100 % agreement between the commercial and laboratory developed tests. No false-negative or false-positive SARS-CoV-2 results were observed and there was no cross-reactivity with common respiratory viruses, including endemic coronaviruses.

SUBMITTER: Dust K 

PROVIDER: S-EPMC7482591 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2.

Dust Kerry K   Hedley Adam A   Nichol Kim K   Stein Derek D   Adam Heather H   Karlowsky James A JA   Bullard Jared J   Van Caeseele Paul P   Alexander David C DC  

Journal of virological methods 20200910


The global COVID-19 pandemic has led to the rapid development of tests for detection of SARS-CoV-2. Studies are required to assess the relative performance of different assays. Here, we compared the performance of two commercial assays, the cobas® SARS-CoV-2 (Roche Diagnostics) and Xpert® Xpress SARS-CoV-2 (Cepheid®) tests, and a laboratory developed RT-PCR test adapted for use on the Hologic® Panther Fusion® (Hologic®) instrument as well as Bio-Rad and QIAGEN real-time PCR detection systems. Pe  ...[more]

Similar Datasets

| S-EPMC7825913 | biostudies-literature
| S-EPMC6145687 | biostudies-literature
| S-EPMC7833356 | biostudies-literature
| S-EPMC8339017 | biostudies-literature
| S-EPMC8026170 | biostudies-literature
| S-EPMC7195305 | biostudies-literature
| S-EPMC8289701 | biostudies-literature
| S-EPMC9930255 | biostudies-literature
| S-EPMC8863925 | biostudies-literature
| S-EPMC7891043 | biostudies-literature